Breaking News Instant updates and real-time market news.

OXY

Occidental Petroleum

$71.30

0.34 (0.48%)

, MPLX

MPLX

$32.08

0.21 (0.66%)

07:30
12/16/16
12/16
07:30
12/16/16
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Thursday in Occidental Petroleum (OXY), MPLX (MPLX), and Sage Therapeutics (SAGE).

OXY

Occidental Petroleum

$71.30

0.34 (0.48%)

MPLX

MPLX

$32.08

0.21 (0.66%)

SAGE

SAGE Therapeutics

$48.99

1.04 (2.17%)

OXY Occidental Petroleum
$71.30

0.34 (0.48%)

08/05/16
DBAB
08/05/16
DOWNGRADE
Target $79
DBAB
Hold
Occidental Petroleum downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Ryan Todd downgraded Occidental Petroleum (OXY) to Hold saying he sees limited drivers of outperformance from current share levels. Moderate crude leverage to a recovery and a dividend/funding gap leaves little available cash flow to accelerate activity, Todd tells investors in a research note. The analyst has a $79 price target for Occidental. He coupled the downgrade with an upgrade of EOG Resources (EOG) to Buy.
10/05/16
MZHO
10/05/16
INITIATION
Target $83
MZHO
Buy
Occidental Petroleum initiated with a Buy at Mizuho
Mizuho analyst Timothy Rezvan initiated Occidental Petroleum with a Buy and a $83 price target.
09/12/16
JPMS
09/12/16
DOWNGRADE
Target $78
JPMS
Underweight
Occidental Petroleum downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Phil Gresh downgraded Occidental Petroleum (OXY( to Underweight saying the valuation is stretched. The stock at current levels fully reflects the company's growth and balance sheet benefits, Gresh tells investors in a research note. He upped his price target for the shares to $78 from $77. Gresh this morning also upgraded ConocoPhillips (COP) to Overweight.
12/16/16
GSCO
12/16/16
UPGRADE
Target $75
GSCO
Neutral
Occidental Petroleum upgraded to Neutral from Sell at Goldman
Goldman analyst Brian Singer upgraded Occidental Petroleum to Neutral and raised its price target to $75 from $70 citing share underperformance and potential clarity on Permian potential.
MPLX MPLX
$32.08

0.21 (0.66%)

11/01/16
UBSW
11/01/16
UPGRADE
Target $44
UBSW
Neutral
Marathon Petroleum upgraded to Neutral from Sell at UBS
UBS analyst Spiro Dounis upgraded Marathon Petroleum to Neutral citing the company's newly announced plans to unlock value in the General Partner and accelerate growth at the MLP. The analyst estimates the General Partner interest in MPLX (MPLX) could be worth $4.6B-$4.8B. He raised his price target for Marathon Petroleum to $44 from $38.
10/31/16
RAJA
10/31/16
UPGRADE
RAJA
Strong Buy
MPLX upgraded to Strong Buy from Market Perform at Raymond James
Raymond James upgraded MPLX (MPLX) two notches to Strong Buy from Market Perform citing the dropdown profile from Marathon Petroleum (MPC) announced last week, combined with the increasing likelihood that the long-term cost of capital concerns of the partnership will be rectified, he believes the current risk/reward appears increasingly positive.
10/31/16
JEFF
10/31/16
UPGRADE
Target $40
JEFF
Buy
MPLX upgraded to Buy from Hold at Jefferies
Jefferies analyst Corey Goldman upgraded MPLX (MPLX) to Buy after Marathon Petroleum (MPC) said it is evaluating options to highlight its MPLX GP value and optimize MPLX's cost of capital. The analyst expects this to result in an accelerated MPLX drop-down schedule. He raised his price target for MPLX and $40 from $35. Goldman also upped his price target for Marathon Petroleum to $59 and keeps a Buy rating on the name.
12/08/16
EVER
12/08/16
UPGRADE
Target $39
EVER
Buy
MPLX upgraded to Buy from Hold at Evercore ISI
Evercore ISI analyst Timm Schneider upgraded MPLX to Buy and raised its price target to $39 from $27. The analysts' updated forecasts assumes an accelerated drop-down schedule and IDR buyout, paving the way for a fair compromise between both activist investors and management.
SAGE SAGE Therapeutics
$48.99

1.04 (2.17%)

12/01/16
WBLR
12/01/16
NO CHANGE
WBLR
Celgene, Zoetis among top healthcare picks at William Blair
William Blair analysts named their top health care picks for 2017, identifying Evolent Health (EVH) as their top HC Services and HC IT pick, Zoetis (ZTS) as their top dental and animal health pick,and Pacific Biosciences (PACB) as their top diagnostic services and life sciences choice, The firm identified ARIAD (ARIA), Celgene (CELG) and SAGE Therapeutics (SAGE) as their top biotech choices. It named Edwards Lifesciences (EW), Nevro (NVRO), and K2M Group (KTWO) as its favorite med tech picks.
12/14/16
RAJA
12/14/16
UPGRADE
Target $84
RAJA
Strong Buy
SAGE Therapeutics upgraded to Strong Buy at Raymond James
As previously reported, Raymond James upgraded Sage Therapeutics to Strong Buy from Buy. Analyst Christopher Raymond said yesterday's R&D event provided an in-depth look at the breadth of the platform and the progress to date. Eight clinical readouts are expected in 2017, with the 1H 2017 STATUS readout in the spotlight, the analyst wrote. He remains encouraged by SAGE's execution, considerable strategic optionality, and thinks at current levels offers a compelling entry point and a positive setup in 2017.
12/14/16
RAJA
12/14/16
UPGRADE
RAJA
Strong Buy
SAGE Therapeutics upgraded to Strong Buy from Outperform at Raymond James
12/07/16
BMOC
12/07/16
NO CHANGE
Target $68
BMOC
Outperform
BMO ups SAGE target to $68 on accelerated depression program
BMO Capital analyst Gary Nachman raised his price target for SAGE Therapeutics to $68 from $57 after the company announced that the ongoing trials for SAGE-547 in postpartum depression will be expanded to qualify as Phase 3, and, if positive, will be sufficient for a new drug application submission. This accelerates the program by about a year, and helps bring forward a key value driver for SAGE, Nachman tells investors in a research note. He raised his estimates for SAGE-547 in postpartum depression by $25M-$150M through 2027. The analyst now expects $350M in sales in 2027. Nachman reiterates an Outperform rating on SAGE, which closed yesterday up $3.86 to $55.68.

TODAY'S FREE FLY STORIES

PTI

Proteostasis

$10.89

-0.21 (-1.89%)

16:34
03/30/17
03/30
16:34
03/30/17
16:34
Hot Stocks
Breaking Hot Stocks news story on Proteostasis »

Proteostasis sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$10.89

-0.21 (-1.89%)

16:33
03/30/17
03/30
16:33
03/30/17
16:33
Earnings
Proteostasis reports Q4 EPS (38c), consensus (52c) »

Reports Q4 R&D…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$17.61

-1.22 (-6.48%)

16:32
03/30/17
03/30
16:32
03/30/17
16:32
Initiation
MacroGenics initiated  »

MacroGenics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

OFED

Oconee Federal Financial Corp

$25.09

-0.66 (-2.56%)

16:32
03/30/17
03/30
16:32
03/30/17
16:32
Hot Stocks
Oconee Federal Financial Corp appoints John Hobbs as CFO »

Oconee Federal Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNOP

KNOT Offshore Partners

$22.60

0.05 (0.22%)

16:31
03/30/17
03/30
16:31
03/30/17
16:31
Hot Stocks
KNOT Offshore Partners to refinance bank loan associated with Hilda Knutsen »

KNOT Offshore Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:31
03/30/17
03/30
16:31
03/30/17
16:31
Options
Preliminary option volume of 13.8M today »

Preliminary option volume…

AKER

Akers Biosciences

$2.15

0.2 (10.26%)

16:28
03/30/17
03/30
16:28
03/30/17
16:28
Syndicate
Akers Biosciences announces $2M private placement »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Mar

FC

Franklin Covey

$16.05

0.1 (0.63%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Hot Stocks
Franklin Covey says affirms FY17 guidance »

Says "the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Mar

XLNX

Xilinx

$57.88

-0.14 (-0.24%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Initiation
Xilinx initiated  »

Xilinx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$15.61

-0.13 (-0.83%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Initiation
Marvell initiated  »

Marvell initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

NRE

Northstar Realty Europe Corp.

$11.63

0.02 (0.17%)

16:27
03/30/17
03/30
16:27
03/30/17
16:27
Hot Stocks
Northstar Realty Europe Corp. CFO Scott Berry to resign, effective May 10 »

On March 27, Scott Berry,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$57.20

-0.16 (-0.28%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Initiation
Qualcomm initiated  »

Qualcomm initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$142.41

-0.24 (-0.17%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Periodicals
Oculus co-founder and Rift creator Palmer Luckey leaves Facebook, Upload says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$69.08

1.23 (1.81%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Initiation
Qorvo initiated  »

Qorvo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

NFX

Newfield Exploration

$36.71

0.41 (1.13%)

16:26
03/30/17
03/30
16:26
03/30/17
16:26
Hot Stocks
Newfield Exploration to build new water recycling facility in Oklahoma »

Newfield Exploration has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

TXN

Texas Instruments

$81.04

0.55 (0.68%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Initiation
Texas Instruments initiated  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 09

    May

NVDA

NVIDIA

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Initiation
NVIDIA initiated  »

NVIDIA initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

FC

Franklin Covey

$16.05

0.1 (0.63%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Earnings
Franklin Covey reports Q2 EPS (24c), consensus (22c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Mar

AMD

AMD

$14.05

0.34 (2.48%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Initiation
AMD initiated  »

AMD initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$876.34

2.02 (0.23%)

, WMT

Wal-Mart

$71.59

0.85 (1.20%)

16:25
03/30/17
03/30
16:25
03/30/17
16:25
General news
On The Fly: Top stock stories for Thursday »

Stock advanced, with the…

AMZN

Amazon.com

$876.34

2.02 (0.23%)

WMT

Wal-Mart

$71.59

0.85 (1.20%)

LULU

lululemon

$50.76

-15.54 (-23.44%)

COP

ConocoPhillips

$50.00

4.05 (8.81%)

GIS

General Mills

$59.07

-0.37 (-0.62%)

MDLZ

Mondelez

$43.28

-0.47 (-1.07%)

TGT

Target

$55.25

0.1 (0.18%)

COST

Costco

$167.89

0.46 (0.27%)

PG

Procter & Gamble

$90.20

-0.4 (-0.44%)

UN

Unilever; also tag UL

$49.86

-0.48 (-0.95%)

UL

Unilever; also tag UN

$49.63

-0.43 (-0.86%)

PEP

PepsiCo

$112.18

-0.25 (-0.22%)

KMB

Kimberly-Clark

$132.24

-0.29 (-0.22%)

CVE

Cenovus Energy

$11.29

-1.79 (-13.69%)

FCX

Freeport McMoRan

$13.31

0.59 (4.64%)

EXTR

Extreme Networks

$7.38

0.92 (14.24%)

BRCD

Brocade

$12.44

0.01 (0.08%)

AVGO

Broadcom

$220.04

-1.27 (-0.57%)

PVTB

PrivateBancorp

$59.00

2.8 (4.98%)

CM

CIBC

$85.31

-2.61 (-2.97%)

CRBP

Corbus Pharmaceuticals

$7.95

-1.05 (-11.67%)

WOR

Worthington

$45.97

-4.66 (-9.20%)

SCWX

SecureWorks

$9.68

-0.65 (-6.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 06

    Apr

  • 06

    Apr

  • 26

    Apr

  • 29

    Apr

  • 09

    May

  • 16

    May

  • 02

    Jun

  • 06

    Jun

  • 20

    Jun

  • 30

    Oct

  • 30

    Mar

16:25
03/30/17
03/30
16:25
03/30/17
16:25
Conference/Events
Federal Reserve Bank of New York President speaks on financial conditions »

New York Federal Reserve…

NH

NantHealth

$5.09

0.13 (2.62%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Earnings
NantHealth reports Q4 adjusted EPS (18c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Mar

  • 06

    Jun

CAVM

Cavium

$71.47

0.11 (0.15%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Initiation
Cavium initiated  »

Cavium initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

  • 09

    May

SWKS

Skyworks

$98.14

0.91 (0.94%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Initiation
Skyworks initiated  »

Skyworks initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

  • 30

    May

AVGO

Broadcom

$220.04

-1.27 (-0.57%)

16:24
03/30/17
03/30
16:24
03/30/17
16:24
Initiation
Broadcom initiated  »

Broadcom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.